If you have ever squinted at the tiny print on a box of flea chews and felt a flicker of worry, you are reading it correctly. Tucked into the labeling for some of the most popular flea and tick preventives on the market is a plain sentence about tremors, stumbling, and seizures. It is unsettling. It is also easy to misread into a panic that leads people to do the single riskiest thing: stop protecting their pet entirely.
So let’s decode the warning the way a veterinarian actually reads it. The short version is that a well-known family of preventives carries a small, real chance of a neurological reaction, that chance is concentrated in a specific group of pets, and knowing which group your pet is in matters far more than the scary word “seizure” on its own.
The one word that ties these products together
The medications in question, Bravecto, NexGard, Credelio, and Simparica, all belong to a drug family called the isoxazolines. That family name is the whole story. These are effective, fast-acting parasiticides that kill fleas and ticks after they bite, and millions of pets take them without incident. But because they act on the nervous system of the parasite, the U.S. Food and Drug Administration has been watching for rare effects on the nervous system of the pet, too.
A quick trick for spotting an isoxazoline: the active ingredient almost always ends in “-laner.” Fluralaner is Bravecto. Afoxolaner is NexGard. Lotilaner is Credelio. Sarolaner is Simparica. The same chemistry shows up in the combination products that fold in heartworm and intestinal parasite coverage, including NexGard Plus, Simparica Trio, Bravecto Plus for Cats, NexGard Combo, and Revolution Plus.
“When a pet parent tells me their dog once had a single seizure years ago, that’s not a small footnote to me, it’s the center of the conversation,” says Dr. Priya Nair. “The medication is safe for the vast majority of pets. My job is to figure out whether yours is in the small group where I’d rather choose a different tool.”
What the FDA actually reported, and what it didn’t
Here is the part the headlines tend to flatten. The FDA did not find that these drugs are dangerous for most pets. What its post-market monitoring found was a pattern of neurological adverse events, muscle tremors, an unsteady wobble known as ataxia, and seizures, reported across the whole isoxazoline class. Because the signal showed up consistently across the products rather than in just one, the agency asked manufacturers to spell the risk out clearly on their labels.
Worth correcting a common gap: the class alert covers four products, not three. Early coverage sometimes named only Bravecto, NexGard, and Credelio, but Simparica has carried neurological-sign language on its label from the start, and it belongs in the same conversation. If your pet takes any “-laner,” the same considerations apply.
The reactions are more likely in pets who already have a history of seizures or neurological disorders. They can, less commonly, appear in a pet with no such history. That is why the honest answer to “is it safe?” is not yes or no. It is “for whom?”
The side effects, product by product
Every drug has a side-effect profile, and the isoxazolines are no exception. Most of these are the ordinary, self-limiting kind rather than neurological events, but it helps to know the full picture.
NexGard (dogs, oral; NexGard Combo is a topical for cats): possible vomiting, diarrhea, dry or flaky skin, a hair change at the application site in the cat formula, and the class-wide neurological signs of tremors, ataxia, and seizures.
Bravecto (dogs, oral or topical, 12 weeks per dose; topical only for cats): possible vomiting, decreased appetite, itching, diarrhea, hair loss in the cat formulas, and an elevation in the liver enzyme ALT in the one-month dog formula and Bravecto Plus for Cats, alongside the class-wide neurological signs.
Credelio (dogs and cats, oral, monthly): possible weight loss, diarrhea, rapid breathing in cats, an elevation in the kidney value BUN seen in geriatric pets, and the class-wide neurological signs.
Simparica (dogs, oral, lasts 35 days): the same neurological cautions, which its label has always carried.
None of this means a reaction is likely. It means the label is complete, and a complete label is a tool, not a threat.
What’s new since the warning: a year-long shot enters the picture
The isoxazoline story kept moving. In July 2025, the FDA approved Bravecto Quantum, the first flea and tick product that protects dogs for eight to twelve months from a single injection given by a veterinarian. It uses fluralaner, the same isoxazoline active ingredient as the original Bravecto chew, so it carries the same class considerations. In the product’s U.S. field study, about 0.9 percent of dogs, two out of 225, had a seizure.
That number is a useful anchor for the whole discussion. It is small, but it is not zero, and it is exactly why the shot is vet-administered rather than sold over the counter. A professional takes the history, decides between the eight- and twelve-month interval based on the ticks in your area, and is there to respond if something goes wrong. The long-acting option is genuinely convenient, and it closes the dangerous gaps that happen when someone forgets a monthly dose. It is not a reason to skip the seizure-history conversation. It is a reason to have it.
The far bigger risk is going without
It is worth saying clearly, because fear pulls people the wrong way: the odds that your pet is harmed by skipping prevention are much higher than the odds of an isoxazoline reaction. Fleas trigger allergic skin disease and can cause anemia in a heavy infestation. Ticks transmit Lyme disease, anaplasmosis, ehrlichiosis, and babesiosis. Mosquitoes carry heartworm, and yes, cats get heartworm too. These are common, and prevention is the wall between your pet and them.
So if the label spooks you, the move is not to quit. It is to switch, if switching is warranted. Preventives come as oral chews, topicals, and collars, built on several different active ingredients. Frontline Plus, Advantage II, Vectra 3D, and the Seresto collar all work without an isoxazoline. For a pet with a seizure history, one of those may be the better fit. Natural or DIY remedies are a different matter: many are neither safe nor effective, so run any of them past your vet before trusting your pet’s protection to them.
How to use these medications with confidence
Give the first dose of a new product on a day you will be home for a few hours, so you can notice a tremor or a wobble early instead of discovering it overnight. Watch for the three signs the FDA tracks: muscle tremors, an unsteady gait, and seizures. If you see any of them, call your veterinarian or an emergency clinic.
And report it. You or your vet can notify the manufacturer, which is required to pass the report to the FDA, or you can report to the FDA directly. Every one of those reports sharpens the safety picture for the next pet.
If your dog or cat has been on one of these products for a while with no trouble, there is no reason to switch. The reaction, when it happens, tends to show itself; a long, uneventful track record is reassuring. The pets who deserve a second look are the new starters and the ones with a neurological history. For them, the label did its job by making you pause. The next step is a two-minute conversation with the person who knows your pet’s chart.
References
- U.S. Food and Drug Administration. “Fact Sheet for Pet Owners and Veterinarians about Potential Adverse Events Associated with Isoxazoline Flea and Tick Products.”
- U.S. Food and Drug Administration. “Animal Drug Safety Communication: FDA Alerts Pet Owners and Veterinarians About Potential for Neurologic Adverse Events Associated with Certain Flea and Tick Products.”
- U.S. Food and Drug Administration. “FDA Approves First Long-Acting Flea and Tick Treatment for Dogs.”
- Palmieri, V. et al. “Survey of canine use and safety of isoxazoline parasiticides.” Veterinary Medicine and Science, 2020.
